Herbal Spotlight
|
|
NEW WARNING
Endo Pharmaceuticals and Novartis issued a "Dear Health Care Professional" letter about revisions made to prescribing information for diclofenac sodium topical gel (Voltaren Gel), a nonsteroidal anti-inflammatory drug indicated for pain associated with osteoarthritis of the knee and hand joints. The revisions include information about the risk for elevated liver test results for all products containing diclofenac sodium. Voltaren Gel is a registered trademark of Novartis AG. Endo Pharmaceuticals has a license agreement with Novartis Consumer Health, Inc. and Novartis AG, which granted Endo Pharmaceuticals exclusive U.S. marketing rights to the product.
For questions related to diclofenac sodium topical gel administration, call the Voltaren Gel call center at 1-800-452-0051.
|
diclofenac sodium, topical gel